Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-26 @ 2:14 AM
NCT ID:
NCT02016105
Pre Assignment Details:
Screening lasted for at least 2 weeks and up to 4 weeks. Main inclusion criteria:
* Men or women of at least 18 years
* Chronic plaque-type psoriasis ≥ 6 months before randomization
* Moderate to severe psoriasis :
* PASI score ≥ 12
* IGA score ≥3
* BSA affected by plaque-type psoriasis ≥ 10%
* No previous exposure to adalimumab
Recruitment Details:
661 patients were screened. 465 patients were randomized 1:1 into Treatment Period 1 and stratified by region (US/EU), body weight (\<90/≥90 kg) and prior systemic therapy (no/any). In Treatment Period 2 patients were re-randomized 2:1 to either continue originally assigned treatment or switch treatment and were stratified by region only.
Study:
NCT02016105
Study Brief:
Results Section:
NCT02016105